Novartis Investigative Site

Ourense, Galicia 32005

0 studies enrolling now · 2 studies all time

What they study most

Chronic Myelogenous Leukemia, Cushing's Disease

Studies at this site

• Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients — Completed
• An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. — Completed